Similar articles

• Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.

  Neumann A, Polis M, Rozenberg L, Jackson J, Reitano K, McLaughlin M, Koratich C, Dewar R, Masur H, Haagmans B, Kottilil S. Neumann A, et al. AIDS. 2007 Sep 12;21(14):1855-65. doi: 10.1097/QAD.0b013e32825eaba7. AIDS. 2007. PMID: 17721093
• PegIFN/ribavirin during acute HCV coinfection.

  Bernard EJ. Bernard EJ. IAPAC Mon. 2004 Jul;10(7):260-1. IAPAC Mon. 2004. PMID: 15624247 No abstract available.
• Delaying HCV treatment in HIV-positive patients.

  Carter M. Carter M. IAPAC Mon. 2005 May;11(5):147. IAPAC Mon. 2005. PMID: 16201045 No abstract available.
• Is time to treat for HCV all the HIV/HCV co-infected hemophiliacs?

  Franchini M. Franchini M. Hematology. 2006 Jun;11(3):209-13. doi: 10.1080/10245330600775287. Hematology. 2006. PMID: 17325964 Review.
• Management of hepatitis C in HIV infected and other immunocompromised individuals.

  Seth AK. Seth AK. Trop Gastroenterol. 2006 Jul-Sep;27(3):111-7. Trop Gastroenterol. 2006. PMID: 17310553 Review.